Gut microbiota and macrophage-neutrophil interactions in the impact of dietary phenolic acids on intestinal inflammation.
RHÖN-KLINIKUM AG continues good business performance – outlook confirmed – Biotech Investments
EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/Miscellaneous First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed 08.08.2024 / 09:00